Defining the Basis of Fibromuscular Dysplasia (FMD)
common.study.values.description
“Defining the Basis of Fibromuscular Dysplasia (FMD)”
The purpose of this study has evolved and expanded since its inception. Originally the intent was to establish the functional, molecular and genetic profile of fibroblasts from Fibromuscular Dysplasia (FMD) patients as compared to carefully matched control subjects. While this remains among the objectives, the study has been expanded to undertake a fully powered cross-tissue systems genetics analysis of FMD, and now also the related arteriopathies spontaneous coronary artery dissection (SCAD) and cervical artery dissection (CvAD). The overall objective is to disclose the core biologic mechanisms of these disorders.
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-no
common.study.methods.is-healthy-no
common.study.methods.no-methods
participant.views.study.view.additional
participant.views.study.view.scientific-title
Defining the Basis of Fibromuscular Dysplasia: The Define-FMD Study
common.study.values.clinical-trial-id
NCT01967511
participant.views.study.view.id
mepk1d
